fbpx
Monday, October 3, 2022
Home Tags Ampyra

Tag: Ampyra

Acorda Therapeutics of Ardsley to cut staff by 15% and make...

Acorda Therapeutics is cutting its workforce by 15% and outsourcing certain unspecified operations, resulting in a savings of $20 million, according to the Ardsley-based...

Acorda patents ruled invalid for MS drug Ampyra

The Ardsley biotech company faces competition from generic manufacturers after a judge ruled four of five patents invalid for Acorda's top-selling drug brand Ampyra.
: